Literature DB >> 30309236

Unplanned 30-Day Hospital Readmissions of Symptomatic Carotid and Vertebral Artery Dissection.

Tapan Mehta1, Smit Patel2, Shailesh Male1, Romil Parikh3, Kathan Mehta4, Kamakshi Lakshminarayan1,3, Ramachandra Tummala5, Mustapha Ezzeddine1.   

Abstract

Entities:  

Year:  2018        PMID: 30309236      PMCID: PMC6186927          DOI: 10.5853/jos.2018.02236

Source DB:  PubMed          Journal:  J Stroke        ISSN: 2287-6391            Impact factor:   6.967


× No keyword cloud information.
Dear Sir: Cervical artery dissection in young adults accounts for 10% to 25% of all ischemic strokes. Sample size is one of the foremost limitations delineated in a majority of the studies evaluating recurrent risk of stroke due to cervical artery dissection [1]. We used the 2014 Nationwide Readmission Database to analyze 30-day unplanned readmissions (30RR) for symptomatic carotid artery dissection (SCAD) (weighted n=2,686) and symptomatic vertebral artery dissection (SVAD) (weighted n=2,837) [2]. Differences in demographic characteristics of both the groups based on the relevant available variables in the database and International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes are described in Table 1. Readmission trends are depicted in Figure 1. Top causes of unplanned readmissions are described in Table 2.
Table 1.

Baseline characteristics of study population

VariableCarotid dissection
Vertebral dissection
ReadmitNon-readmitPReadmitNon-readmitP
Number2442,4422392,598
Age55.6±2.053.2±0.60.2453.1±1.848.1±0.5<0.01
Charlson’s Index2.4±0.22.0±0.10.061.8±0.21.5±0.00.05
Median household income category for patient’s zip code (percentile) (%)0.410.95
 0–25th24.318.815.016.7
 26–50th20.124.220.622.0
 51–75th23.127.531.030.6
 76–100th32.529.433.430.7
Primary payer (%)0.03<0.01
 Medicare29.624.836.718.6
 Medicaid21.612.117.110.8
 Private insurance41.153.139.761.8
 Self-pay/no charge/other7.79.26.68.7
Length of hospital stay in days (LOS)<0.01<0.01
 Medicare8.8±1.77.3±0.57.9±1.17.7±0.6
 Medicaid14.4±4.612.7±1.410.1±2.97.5±0.7
 Private insurance8.8±1.77.2±0.44.3±0.66.1±0.4
 Self-pay/no charge/other3.2±0.79.7±1.89.7±3.57.7±1.8
Hospital bed size0.010.21
 Small4.57.73.78.1
 Medium30.417.420.920.9
 Large65.174.975.471.0
Admission type (%)0.460.92
 Non-elective92.890.295.595.2
 Elective7.29.84.54.8
Admission day (%)0.890.88
 Weekdays74.875.676.076.6
 Weekend25.324.424.123.4
Disposition (%)0.01<0.01
 Home55.171.256.774.2
 Home health care11.98.39.910.5
 Facility31.419.932.515.0
 Against medical advice1.60.60.90.3
Comorbidities (%)
 Hypertension60.551.00.0761.659.10.65
 Hyperlipidemia33.242.00.1636.538.40.68
 Atrial fibrillation13.84.10.0110.58.50.51
 Smoking17.517.80.9323.721.00.62
 Heart failure4.82.70.223.84.10.89
 Ischemic heart disease13.48.50.1316.510.90.08
 Atherosclerosis3.51.00.062.31.40.42
 Diseases of endocardium3.52.60.634.43.30.63
 Diabetes14.314.30.9920.814.10.1
 Intracerebral hemorrhage3.42.00.328.03.60.02
 Hypercoagulable state0.81.00.81.61.50.96
 Subarachnoid hemorrhage0.00.82.21.00.47
 Trauma related injury to blood vessel of head and neck0.70.50.80.80.40.55
 Unruptured aneurysm (aortic, peripheral)7.73.90.232.02.80.55
 Intravenous thrombolytic use15.512.10.346.04.90.71
 Mechanical thrombectomy8.35.20.33.71.10.06
 Endovascular procedure other than mechanical thrombectomy5.12.60.083.22.40.41

Values are presented as mean±standard deviation or number (%). Unpaired t-test was used for continuous variables, and chi-square test or Fisher’s exact test was used for categorical variables.

Figure 1.

Readmission trends for symptomatic carotid and vertebral artery dissection.

Table 2.

Top causes of 30RR in carotid and vertebral artery dissection

No.Carotid dissection
Vertebral dissection
CausesCause specific 30RRTotal readmissions (%)CausesCause specific 30RRTotal readmissions (%)
1Ischemic stroke1.610.4Ischemic stroke4.130.8
2Intracranial hemorrhage1.38.2Aortic; peripheral; and visceral artery aneurysms0.96.6
3Aortic; peripheral; and visceral artery aneurysms1.27.5Late effects of cerebrovascular disease0.85.9
4Retinal disorders0.95.5Connective tissue disease0.43.2
5Transient cerebral ischemia0.74.6Occlusion or stenosis of precerebral arteries0.42.8
6Intestinal infection0.64.0Headache0.42.8
7Venous embolism and thrombosis0.64.0Gram negative septicemia0.42.8
8Nonspecific chest pain0.63.6Unspecified septicemia0.42.8
9Unspecified septicemia0.53.2Nervous system symptoms and disorders other than stroke0.32.4
10Nervous system symptoms and disorders other than stroke0.42.4Nonmalignant breast conditions0.32.2

30RR, 30-day unplanned readmission.

Overall 30RR for SCAD was not significantly higher than SVAD (9.08% vs. 8.43%, P=0.412). Overall unplanned readmissions due to ischemic strokes in our study are similar to the findings of the CADISS trial1; however, 30RR due to ischemic stroke were higher in SVAD compared to SCAD (4.14% vs. 1.60%, P<0.001). Approximately 50% of total readmissions for first 30 days were admitted by day 7 in both SCAD and SVAD groups [3,4]. Higher incidence of intracranial dissection with SVAD compared to SCAD potentially explains higher intracranial hemorrhage with SVAD (intracerebral hemorrhage: 11.62% vs. 5.41%, P<0.001; subarachnoid hemorrhage: 3.21% vs. 0.78%, P<0.001) [5]. The incidence of intracerebral hemorrhage amongst readmitted patients was also significantly higher with SVAD (7.9943% vs. 3.6257%, P=0.016). These findings are less likely to be related to reperfusion therapies, as anterior circulation infarcts tend to have higher hemorrhagic transformation rates [6]. We also noted a higher incidence of reperfusion therapies with carotid dissections. Peripheral, visceral and aortic artery aneurysms were present in 11.55% patients with SCAD (related 30RR 1.16%, third leading cause) and 4.73% patients with SVAD patients (related 30RR 0.88%, second leading cause). These findings suggest that there might be some value of having a low threshold to screen these patients for additional vascular abnormalities, especially those with known connective tissue disorders. Tertiary care centers are reported to have poorer outcomes for cervical artery dissections, as complicated cases are usually referred to such institutions [7]. Our study too showed a higher readmission trend in larger size hospitals. Medicare and Medicaid as primary payer had higher rates of readmission compared to private insurance along with length of hospital stay as described in Table 1. It is important to consider that quality of access to care after discharge from hospital could be a contributing factor leading to higher readmissions in such population. The study findings need to be taken into consideration in light of shortcomings intrinsic to secondary analysis of a large administrative database. We were not able to identify the approach for medical management during index hospitalization (i.e., anticoagulant vs. antiplatelet therapy), imaging information, location of dissection (intra vs. extracranial), and degree of vessel stenosis. Knowledge of these point of care clinical information would certainly further help identify the root causes of differences in readmission risk. Despite these limitations, our study represents one of the largest cohort of symptomatic cervical artery dissection cases and contributes to current understanding of primary etiologies and demographic differences of 30 days readmissions. It shows that overall readmission rates are not significantly different for SCAD and SVAD. However, patients with vertebral artery dissections have higher rates of readmission with ischemic stroke and also are more likely to have intracranial hemorrhage.
  6 in total

1.  Aspirin versus anticoagulation in intra- and extracranial vertebral artery dissection.

Authors:  A Arauz; A Ruiz; G Pacheco; P Rojas; M Rodríguez-Armida; C Cantú; L Murillo-Bonilla; J L Ruiz-Sandoval; F Barinagarrementeria
Journal:  Eur J Neurol       Date:  2012-07-20       Impact factor: 6.089

2.  Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial.

Authors:  Hugh S Markus; Elizabeth Hayter; Christopher Levi; Adina Feldman; Graham Venables; John Norris
Journal:  Lancet Neurol       Date:  2015-02-12       Impact factor: 44.182

3.  Cervical artery dissection: risk factors, treatment, and outcome; a 5-year experience from a tertiary care center.

Authors:  Shadi Yaghi; Nancy Maalouf; Salah G Keyrouz
Journal:  Int J Neurosci       Date:  2011-10-13       Impact factor: 2.292

Review 4.  Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection.

Authors:  Stéphanie Debette; Annette Compter; Marc-Antoine Labeyrie; Maarten Uyttenboogaart; Tina M Metso; Jennifer J Majersik; Barbara Goeggel-Simonetti; Stefan T Engelter; Alessandro Pezzini; Philippe Bijlenga; Andrew M Southerland; Olivier Naggara; Yannick Béjot; John W Cole; Anne Ducros; Giacomo Giacalone; Sabrina Schilling; Peggy Reiner; Hakan Sarikaya; Janna C Welleweerd; L Jaap Kappelle; Gert Jan de Borst; Leo H Bonati; Simon Jung; Vincent Thijs; Juan J Martin; Tobias Brandt; Caspar Grond-Ginsbach; Manja Kloss; Tohru Mizutani; Kazuo Minematsu; James F Meschia; Vitor M Pereira; Anna Bersano; Emmanuel Touzé; Philippe A Lyrer; Didier Leys; Hugues Chabriat; Hugh S Markus; Bradford B Worrall; Stéphane Chabrier; Ralph Baumgartner; Christian Stapf; Turgut Tatlisumak; Marcel Arnold; Marie-Germaine Bousser
Journal:  Lancet Neurol       Date:  2015-06       Impact factor: 44.182

5.  Frequency and determinants for hemorrhagic transformation of cerebral infarction.

Authors:  Valeria Terruso; Marco D'Amelio; Norma Di Benedetto; Innocenzo Lupo; Valentina Saia; Giorgia Famoso; Maria Antonietta Mazzola; Paolo Aridon; Caterina Sarno; Paolo Ragonese; Giovanni Savettieri
Journal:  Neuroepidemiology       Date:  2009-07-27       Impact factor: 3.282

6.  Antiplatelets vs anticoagulation for dissection: CADISS nonrandomized arm and meta-analysis.

Authors:  Fiona Kennedy; Silvia Lanfranconi; Cara Hicks; John Reid; Patrick Gompertz; Christopher Price; Sally Kerry; John Norris; Hugh S Markus
Journal:  Neurology       Date:  2012-08-01       Impact factor: 9.910

  6 in total
  1 in total

1.  Long-Term Outcomes of Stenting on Non-Acute Phase Extracranial Supra-Aortic Dissections.

Authors:  Yeqing Jiang; Ruoyu Di; Gang Lu; Lei Huang; Hailin Wan; Liang Ge; Xiaolong Zhang
Journal:  J Korean Neurosurg Soc       Date:  2022-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.